Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03596203 · ClinicalTrials.gov registry record · Phase 1
TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy
A Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03596203: Completed Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT03596203 is a Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03596203, a Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The study will evaluate whether an experimental medical device that emits a series of brief, intense magnetic pulse will relieve foot pain from Diabetic Neuropathy (DN). The United States Food and Drug Administration (FDA) has approved a similar device for treatment of migraine headaches, but this type of device has not been studied for the treatment of DN.
Primary Outcome
Numeric Pain Rating Scale, 0-10 with 0 being no pain, and 10 being worst pain ever experienced
Interventions
- DEVICE TransCutaneous Magnetic Stimulator (TCMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-07-30 |
| Phase | Phase 1 |
What the finished NCT03596203 record still lists
NCT03596203 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which TransCutaneous Magnetic Stimulator (TCMS) is the first listed.
NCT03596203 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03596203 about?
NCT03596203 is a clinical study titled "TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy". The study will evaluate whether an experimental medical device that emits a series of brief, intense magnetic pulse will relieve foot pain from Diabetic Neuropathy (DN). The United States Food and Drug Administration (FDA) has approved a similar device for treatment of migraine headaches, but this t...
What is the current status of trial NCT03596203?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2018-11-01. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03596203?
The interventions under investigation include: TransCutaneous Magnetic Stimulator (TCMS) (DEVICE).
Who is sponsoring clinical trial NCT03596203?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03596203's enrollment target sits among peer trials
17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI